Growth Metrics

Burning Rock Biotech (BNR) Assets Average: 2021-2024

Historic Assets Average for Burning Rock Biotech (BNR) over the last 4 years, with Dec 2024 value amounting to $133.9 million.

  • Burning Rock Biotech's Assets Average fell 16.10% to $481.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $481.4 million, marking a year-over-year decrease of 16.10%. This contributed to the annual value of $133.9 million for FY2024, which is 28.91% down from last year.
  • Burning Rock Biotech's Assets Average amounted to $133.9 million in FY2024, which was down 28.91% from $188.3 million recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's Assets Average peaked at $382.8 million during FY2021, and registered a low of $133.9 million during FY2024.
  • Its 3-year average for Assets Average is $205.4 million, with a median of $188.3 million in 2023.
  • Its Assets Average has fluctuated over the past 5 years, first grew by 23.24% in 2022, then crashed by 35.91% in 2023.
  • Burning Rock Biotech's Assets Average (MRY) stood at $382.8 million in 2021, then dropped by 23.24% to $293.9 million in 2022, then plummeted by 35.91% to $188.3 million in 2023, then dropped by 28.91% to $133.9 million in 2024.
  • Its Assets Average was $133.9 million in FY2024, compared to $188.3 million in FY2023 and $293.9 million in FY2022.